Erectile dysfunction is one of the most common health conditions affecting men and one of the least honestly discussed. More than 30 million American men experience it. The majority never receive an adequate workup. Most are handed a prescription for sildenafil or tadalafil, told to take it as needed, and sent on their way. The underlying cause — the reason the problem exists in the first place — goes uninvestigated and untreated.
That is a problem, because erectile dysfunction is not a disease. It is a symptom. It is frequently the first visible sign of cardiovascular disease, hormonal imbalance, metabolic dysfunction, or neurological damage. Treating it with a pill that temporarily increases blood flow to the penis without asking why blood flow is compromised in the first place is like putting tape over the check engine light. The light goes off. The engine is still failing.
This guide is designed to do what most ED resources do not: explain the full range of causes behind erectile dysfunction, identify the hormonal factors that are routinely missed, lay out every treatment option with honest assessments of what works and what does not, and address the relationship and psychological dimensions that make this condition uniquely difficult to deal with. Whether you are experiencing ED yourself or supporting a partner who is, this is the most complete, judgment-free resource we can build.
What is erectile dysfunction?
Erectile dysfunction is defined as the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. The key word is consistent. Every man will experience an occasional inability to get or maintain an erection at some point. Stress, alcohol, fatigue, lack of sleep, distraction — all of these can cause a one-off episode that is entirely normal and not medically significant. Erectile dysfunction, as a clinical condition, refers to a persistent pattern that occurs across multiple sexual encounters over a period of weeks or months.
The prevalence is staggering and consistently underreported. Conservative estimates put the number at 30 million American men, though the actual figure is almost certainly higher given how many men never seek treatment. Prevalence increases with age but not in the way most people assume. Roughly 40% of men experience some degree of ED by age 40. By age 70, that figure approaches 70%. But ED is not a normal part of aging. Age-related declines in hormone levels, cardiovascular health, and metabolic function increase the risk, but a healthy 65-year-old should be able to achieve and maintain erections. The assumption that ED is simply "what happens when you get older" causes millions of men to accept a treatable condition as inevitable.
What makes erectile dysfunction medically important — beyond its impact on sexual health and quality of life — is what it signals about the rest of the body. The penile arteries are among the smallest arteries in the body. When vascular disease begins to compromise blood flow, the smallest vessels are affected first. This means that erectile dysfunction often appears 3 to 5 years before a man experiences symptoms of coronary artery disease. ED can be an early warning system for heart attack and stroke. It can be the first sign of undiagnosed diabetes or metabolic syndrome. It can signal a hormonal collapse that is affecting every system in the body, not just sexual function.
This is why the standard approach of prescribing a PDE5 inhibitor without further investigation is not just inadequate — it is potentially dangerous. A man who presents with ED deserves a comprehensive evaluation that investigates the root cause. He may need cardiovascular screening. He almost certainly needs hormone testing. He may need metabolic workup. The erection problem is the signal. The question is what it is signaling.
Causes of erectile dysfunction
Erectile function requires the coordination of multiple body systems: hormonal signaling to drive arousal, neurological pathways to transmit signals from the brain to the penis, vascular function to deliver blood flow, smooth muscle relaxation to allow engorgement, and psychological readiness to initiate the entire process. A breakdown in any one of these systems can cause ED. In many men, multiple causes overlap simultaneously, which is part of why single-intervention approaches often fall short.
Hormonal causes
Hormonal dysfunction is the most underdiagnosed cause of erectile dysfunction. The majority of men who present to their primary care physician with ED never receive comprehensive hormone testing. They get a total testosterone level at best — and if it falls anywhere within the absurdly broad "normal" range of 264–916 ng/dL, they are told their hormones are fine. They are not fine. A man with a total testosterone of 320 ng/dL is technically "normal" and functionally hypogonadal. His body does not have the androgenic support it needs for healthy erectile function, and no amount of sildenafil will fix that.
Low testosteroneis the most common hormonal driver of ED. Testosterone is required for libido (the desire component of sexual function) and plays a direct role in the nitric oxide signaling cascade that triggers erections. Men with low testosterone often report not just difficulty with erections but a decline in sexual desire itself — a distinction that points toward a hormonal rather than vascular cause. Low testosterone also contributes to fatigue, depression, reduced muscle mass, and increased body fat, all of which independently worsen ED.
Elevated estradiolis the second hormonal cause that gets missed. Men produce estradiol through aromatization of testosterone. When estradiol is disproportionately high relative to testosterone — common in men with excess body fat, which increases aromatase activity — it can suppress libido, impair erectile function, and cause water retention, mood instability, and gynecomastia. The ratio between testosterone and estradiol matters more than either number in isolation.
Thyroid dysfunctionaffects erectile function through multiple mechanisms. Both hypothyroidism and hyperthyroidism are associated with ED. Hypothyroidism slows metabolic rate, reduces energy, and impairs the production and metabolism of sex hormones. Many men with subclinical hypothyroidism — a TSH above 2.5 but below the lab's flagged range — experience fatigue, weight gain, and sexual dysfunction without ever being told their thyroid is contributing.
Elevated cortisol from chronic stress directly suppresses testosterone production through the hypothalamic-pituitary-gonadal (HPG) axis. Cortisol and testosterone have an inverse relationship: when one goes up, the other tends to go down. A man under chronic work stress, sleeping poorly, and running on caffeine and cortisol is physiologically suppressing the very hormone he needs for sexual function. This is one of the most common patterns we see and one of the most fixable. For more on how cortisol affects the body, see our guide on high cortisol symptoms.
Low DHEA compounds the problem. DHEA is a precursor to both testosterone and estrogen, and levels decline significantly with age. Low DHEA-S levels are associated with ED independent of testosterone levels, suggesting that DHEA plays a direct role in sexual function beyond its contribution as a testosterone precursor.
This is Nuletic's core angle on erectile dysfunction: in a significant percentage of cases, ED is a hormone problem that PDE5 inhibitors mask but do not fix. A man with testosterone at 300 ng/dL, elevated estradiol, subclinical hypothyroidism, and high cortisol does not have a sildenafil deficiency. He has a hormonal environment that is incompatible with healthy sexual function. Fix the hormones, and the erections often fix themselves. For a deeper dive into this approach, see our complete guide to hormone optimization.
Vascular causes
Erections are fundamentally a vascular event. Arousal triggers the release of nitric oxide, which relaxes smooth muscle in the penile arteries, allowing blood to flow into the corpora cavernosa and produce rigidity. Anything that compromises arterial blood flow or impairs nitric oxide production can cause ED.
Atherosclerosis— the buildup of plaque in arterial walls — is the most common vascular cause of ED and the reason erectile dysfunction is considered a predictor of cardiovascular events. The penile arteries are 1–2 mm in diameter, roughly half the size of coronary arteries. When atherosclerosis begins to narrow blood vessels, the smallest arteries are affected first. Studies consistently show that ED precedes clinically significant coronary artery disease by 3 to 5 years. A man who develops ED at 50 without an obvious cause should be treated as a cardiovascular risk patient until proven otherwise.
Hypertension damages the endothelial lining of blood vessels over time, impairing their ability to dilate in response to nitric oxide. High blood pressure is both a direct cause of ED and an indirect cause through the medications used to treat it (more on that below).
Diabetes causes ED through vascular and neurological mechanisms simultaneously. Chronically elevated blood sugar damages blood vessel walls (diabetic vasculopathy) and peripheral nerves (diabetic neuropathy). Roughly 50% of men with diabetes experience ED, making it one of the strongest risk factors. Type 2 diabetes is frequently accompanied by obesity, insulin resistance, and low testosterone, creating a cascade of factors that all contribute to sexual dysfunction.
Metabolic syndrome— the cluster of conditions including abdominal obesity, high blood pressure, elevated blood sugar, high triglycerides, and low HDL cholesterol — is increasingly recognized as a major driver of ED in men under 50. Metabolic syndrome creates systemic inflammation, impairs endothelial function, promotes insulin resistance, and suppresses testosterone production. It is both a cause of ED and a warning sign that cardiovascular disease is developing.
Neurological causes
The neural pathway from arousal to erection involves the brain, spinal cord, and peripheral nerves. Damage at any point along this pathway can cause ED.
Diabetic neuropathy is the most common neurological cause. Chronically elevated blood sugar damages the peripheral nerves that carry signals from the spinal cord to the penis. This damage is often gradual and progressive, with ED worsening over time as neuropathy advances.
Multiple sclerosiscauses demyelination of nerve fibers throughout the central nervous system, frequently affecting the neural pathways involved in sexual function. ED is reported by 50–75% of men with MS.
Spinal cord injuries can disrupt the neural pathways between the brain and the pelvic region. The degree of ED depends on the location and completeness of the injury. Some men with spinal cord injuries can achieve reflex erections (mediated by the spinal cord) but not psychogenic erections (mediated by the brain), or vice versa.
Post-surgical damageis a significant cause of ED following radical prostatectomy for prostate cancer. Despite advances in nerve-sparing surgical techniques, damage to the cavernous nerves that run alongside the prostate remains common. Post-prostatectomy ED can be temporary (nerve bruising that resolves over 6–24 months) or permanent (nerve transection). Pelvic surgeries for bladder cancer and colorectal cancer carry similar risks.
Psychological causes
The brain is the most important sexual organ. Psychological factors can cause ED on their own and frequently amplify physical causes, creating a vicious cycle that is difficult to break without addressing both dimensions.
Performance anxiety is the most common psychological cause, particularly in younger men. The fear of not being able to perform triggers a sympathetic nervous system response (fight-or-flight) that directly opposes the parasympathetic response required for erection. One failed erection creates anxiety about the next encounter, which increases the likelihood of another failure, which deepens the anxiety. This cycle can transform a single stress-related episode into a persistent pattern that feels indistinguishable from a physical problem.
Depressionimpairs sexual function through multiple mechanisms: reduced libido, anhedonia (loss of pleasure), fatigue, and neurochemical changes that affect arousal pathways. Depression and ED have a bidirectional relationship — each worsens the other. Complicating matters further, many antidepressant medications (particularly SSRIs) cause or worsen ED as a side effect, creating a treatment dilemma that requires careful management.
Relationship stressaffects sexual function in ways that are difficult to separate from the physical. Unresolved conflict, emotional distance, resentment, communication breakdown, and loss of intimacy all reduce sexual desire and can impair arousal even when desire is present. Many men who present with "ED" actually have a relationship problem that manifests sexually.
Porn-induced erectile dysfunctionis a real and increasingly documented phenomenon, though it remains controversial in some clinical circles. The hypothesis is that chronic, heavy pornography use can desensitize the brain's dopamine reward pathways, leading to a situation where a man can achieve erections to pornographic stimuli but not with a real partner. This is not a moral argument about pornography. It is a neurological observation about dopamine receptor downregulation in response to supranormal stimuli. The clinical pattern is distinct: healthy young men with no vascular, hormonal, or other physical cause of ED who can achieve erections during masturbation to pornography but not during partnered sex. Treatment typically involves a period of abstinence from pornography and often responds well, supporting the hypothesis that the issue is neuroplastic rather than structural.
It is important to note that psychological and physical causes are not mutually exclusive. In fact, they rarely occur in isolation. A man with moderately low testosterone may not have noticed a problem until he experienced a stress-related episode of ED, which then triggered performance anxiety that made the low testosterone's effects far worse than they would have been on their own. Effective treatment requires addressing both the physical substrate and the psychological overlay.
Medication-induced ED
A surprising number of commonly prescribed medications can cause or worsen erectile dysfunction. Many men do not realize their medication is the problem because the onset is gradual and the connection is never made explicit by their prescribing physician.
SSRIs and SNRIs (selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors) are among the most common offenders. Sertraline (Zoloft), fluoxetine (Prozac), paroxetine (Paxil), escitalopram (Lexapro), and venlafaxine (Effexor) all carry significant rates of sexual side effects including reduced libido, difficulty with erection, and delayed or absent orgasm. Rates vary by medication but can exceed 50% for some SSRIs. The cruel irony is that these medications are often prescribed for depression, which itself causes sexual dysfunction, making it difficult to distinguish the disease from the treatment.
Beta-blockers used for hypertension (atenolol, metoprolol, propranolol) can cause ED by reducing cardiac output and blocking the adrenergic signals involved in sexual arousal. Newer beta-blockers like nebivolol, which has nitric oxide-enhancing properties, appear to have a lower incidence of sexual side effects.
Finasteride (Propecia, Proscar), used for hair loss and benign prostatic hyperplasia, inhibits 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT). DHT plays a role in sexual function, and finasteride use is associated with ED, reduced libido, and in some cases a persistent sexual dysfunction syndrome that continues after discontinuation of the drug. This is a critical consideration for men taking finasteride for hair loss who may not have been adequately informed about sexual side effects.
Statinshave a complex relationship with ED. By lowering cholesterol, they may reduce the substrate available for steroid hormone synthesis (cholesterol is the precursor to testosterone). Some studies show a modest association between statin use and reduced testosterone or sexual dysfunction. However, by improving cardiovascular health, statins may also improve ED in men with vascular causes. The net effect likely depends on the individual patient's specific circumstances.
Antihistamines (diphenhydramine, cimetidine) can impair erectile function through anticholinergic effects. Cimetidine (Tagamet) additionally has anti-androgenic properties and can lower testosterone levels with chronic use.
If you suspect a medication is contributing to your ED, do not stop taking it without consulting your physician. In many cases, switching to an alternative medication within the same class can resolve the sexual side effects without compromising treatment of the underlying condition.
Lifestyle factors
Lifestyle factors are both the most common contributors to ED and the most modifiable. They rarely cause ED in isolation but amplify every other risk factor on this list.
Obesity is one of the strongest lifestyle risk factors for ED. Excess body fat, particularly visceral abdominal fat, increases aromatase activity (converting testosterone to estrogen), promotes insulin resistance, drives systemic inflammation, and impairs endothelial function. A man who is 40 pounds overweight is fighting his own biology on every front that matters for erectile function. The encouraging flip side: weight loss consistently improves ED, with studies showing significant improvement for every 10 pounds lost.
Sedentary behavior impairs cardiovascular function, promotes insulin resistance, reduces nitric oxide production, and contributes to weight gain. Men who exercise regularly have significantly lower rates of ED than sedentary men across all age groups.
Alcohol in moderate amounts may reduce performance anxiety and has minimal impact on erectile function. Chronic heavy drinking, however, causes liver damage (impairing estrogen metabolism), neuropathy, testosterone suppression, and direct toxic effects on testicular tissue. Alcohol-related ED is dose-dependent and often reversible with reduction or cessation.
Smoking damages the endothelial lining of blood vessels, accelerates atherosclerosis, and impairs nitric oxide production. Smokers have roughly double the risk of ED compared to non-smokers. Quitting smoking improves endothelial function within weeks and reduces ED risk over time.
Poor sleepsuppresses testosterone production, elevates cortisol, impairs insulin sensitivity, and disrupts the neuroendocrine signaling required for healthy sexual function. Testosterone is produced primarily during deep sleep, and men who consistently sleep fewer than 6 hours have measurably lower testosterone levels than those who sleep 7–9 hours. Sleep apnea is a particularly insidious contributor: it fragments sleep architecture, suppresses testosterone, and is independently associated with ED even after controlling for obesity and age.
Chronic stress elevates cortisol, suppresses testosterone, activates the sympathetic nervous system (opposing the parasympathetic response needed for erection), and contributes to anxiety, depression, and relationship strain. Stress-related ED is extremely common in high-performing professionals and is one of the most underrecognized patterns in clinical practice.
The hormone connection your doctor is missing
Here is the pattern we see repeatedly in patient accounts and clinical data: a man in his late 30s or 40s develops ED. He goes to his primary care physician or a urologist. If he is lucky, he gets a total testosterone level drawn. If that level is anywhere above 264 ng/dL — the bottom of the reference range — he is told his hormones are "normal." He is prescribed Viagra or Cialis. He takes it. It works, at least partially. The underlying cause of his ED goes completely unaddressed. His testosterone continues to decline. His metabolic health continues to deteriorate. His cardiovascular risk continues to climb. But the pills work, so the problem is considered solved.
This is not an edge case. This is the standard of care in most of American medicine. PDE5 inhibitors are an $8 billion global market because they are being prescribed to virtually every man who walks in the door with ED, regardless of the underlying cause. They work on the symptom — insufficient blood flow to the penis — without addressing why blood flow is insufficient in the first place.
A man with testosterone at 300 ng/dL and ED will respond better to testosterone replacement plus lifestyle optimization than to Cialis alone. The Cialis may help him get an erection tonight, but it will not restore his energy, his cognitive function, his muscle mass, his motivation, or his overall metabolic health. TRT, by contrast, addresses the systemic hormonal deficit that is causing his ED along with a constellation of other symptoms he may not have connected. The erection problem is not the only thing low testosterone is doing to him. It is just the one that forced him to seek help.
Any man presenting with ED should receive a comprehensive hormone panel that includes, at minimum:
- Total and free testosterone— both are necessary because SHBG can bind testosterone and reduce bioavailable levels even when total testosterone appears adequate
- Estradiol (sensitive assay)— to evaluate the testosterone-to-estradiol ratio and identify aromatization issues
- SHBG— sex hormone-binding globulin levels determine how much of your total testosterone is actually available to tissues
- Thyroid panel(TSH, free T3, free T4) — subclinical thyroid dysfunction affects energy, metabolism, and sexual function
- Fasting insulin and glucose— insulin resistance is both a cause and an accelerant of ED
- Lipid panel— to assess cardiovascular risk given that ED is a vascular warning signal
- DHEA-S— a marker of adrenal function and an independent contributor to sexual health
- Prolactin— elevated prolactin suppresses testosterone and libido
If your physician prescribed ED medication without ordering these labs, you received an incomplete evaluation. The pill may work in the short term, but you deserve to know why you needed it in the first place. For a deep dive into the optimization approach, see our full guide on hormone optimization. If you are looking for a clinic that takes this approach today, our comparison of the best online TRT and optimization clinics evaluates which providers actually do comprehensive testing versus those that just write prescriptions.
Treatment options
There is no single best treatment for erectile dysfunction because there is no single cause. The right treatment depends on the underlying driver or, more commonly, the combination of drivers. What follows is an honest assessment of every major treatment category, including what works, what does not, what the evidence says, and what nobody tells you.
Hormone optimization
For men whose ED is driven by hormonal dysfunction — low testosterone, elevated estradiol, thyroid imbalance, high cortisol, or some combination — hormone optimization addresses the root cause rather than masking the symptom. This is not a quick fix. Testosterone replacement therapy typically takes 4 to 12 weeks before meaningful improvements in sexual function are noticed, with full optimization often requiring 3 to 6 months of iterative protocol adjustments.
Testosterone replacement is the foundation for men with documented low testosterone. TRT restores androgenic signaling throughout the body, improving not just erectile function but energy, mood, cognitive clarity, body composition, and metabolic health. The improvement in sexual function is typically most pronounced in men whose primary cause of ED is hormonal rather than vascular. A man with low testosterone and clean arteries will likely see dramatic improvement. A man with low testosterone and significant atherosclerosis may improve partially but will also need vascular interventions.
Estrogen managementmatters because testosterone therapy can increase estradiol through aromatization, potentially worsening the testosterone-to-estradiol ratio even as total testosterone improves. A skilled optimization physician monitors estradiol throughout TRT and adjusts the protocol — through dosage modification, injection frequency changes, or judicious use of aromatase inhibitors — to maintain an appropriate balance.
Thyroid optimization can have a dramatic impact on sexual function in men with subclinical or clinical hypothyroidism. Restoring optimal thyroid function improves energy, metabolism, and the production and metabolism of sex hormones. Many men are surprised to find that addressing their thyroid significantly improves ED symptoms they assumed were purely a testosterone issue.
The hormone optimization approach to ED is fundamentally different from the PDE5 inhibitor approach. It takes longer. It requires comprehensive testing. It demands ongoing monitoring. But it addresses the actual cause, which means the improvement is durable rather than dependent on taking a pill every time you want to have sex. For the full framework, see our guide to hormone optimization.
PDE5 inhibitors
Phosphodiesterase type 5 inhibitors are the most widely prescribed treatment for ED and remain the first-line pharmacological therapy for most patients. They work by inhibiting the PDE5 enzyme, which breaks down cyclic GMP, the molecule responsible for smooth muscle relaxation in the penile arteries. By blocking PDE5, these drugs prolong the effect of nitric oxide signaling, allowing more blood to flow into the penis and producing a firmer, more sustainable erection.
Sildenafil (Viagra)was the first PDE5 inhibitor approved for ED and remains the most recognized. It takes effect in 30–60 minutes, lasts 4–6 hours, and works best on an empty stomach (fatty meals delay absorption significantly). Standard doses are 25, 50, and 100 mg, with most men starting at 50 mg.
Tadalafil (Cialis)has a significantly longer half-life — up to 36 hours — earning it the nickname "the weekend pill." It is less affected by food intake than sildenafil. Tadalafil is also available as a daily low-dose option (2.5 or 5 mg), which maintains a steady baseline level in the blood and eliminates the need to plan dosing around sexual activity. Daily tadalafil also has benefits for benign prostatic hyperplasia (BPH) and may improve endothelial function over time with regular use. For men who want spontaneity rather than planning, daily low-dose tadalafil is often the preferred option.
Vardenafil (Levitra) and avanafil (Stendra) are alternatives with slightly different pharmacokinetic profiles. Avanafil has the fastest onset of action (15–30 minutes) and may have fewer side effects due to its greater selectivity for PDE5 over other phosphodiesterase enzymes.
PDE5 inhibitors are effective for approximately 70–80% of men across all causes of ED. They are generally well tolerated. Common side effects include headache, facial flushing, nasal congestion, dyspepsia, and in the case of sildenafil, a temporary blue-tinged visual disturbance. They are contraindicated in men taking nitrates (for angina) due to the risk of severe hypotension.
The limitation of PDE5 inhibitors is that they do not address the underlying cause of ED. They improve the symptom — and they do it well — but they do not fix the hormonal deficit, the vascular damage, the metabolic dysfunction, or the psychological pattern that created the problem. For many men, PDE5 inhibitors are an appropriate bridge while root causes are being investigated and treated. For some, they remain a long-term component of a broader protocol. But they should never be the only intervention.
Peptide therapy
PT-141 (bremelanotide)represents a fundamentally different approach to treating ED. Unlike PDE5 inhibitors, which work on blood flow, PT-141 acts on melanocortin receptors in the brain's hypothalamus, directly stimulating the central arousal pathways that initiate sexual desire and response. It works on the brain, not the blood vessels.
PT-141 was FDA-approved in 2019 as Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. In men, it is used off-label for ED, particularly in cases where PDE5 inhibitors are ineffective or poorly tolerated. Because its mechanism is neurological rather than vascular, PT-141 can work in men whose ED does not respond to Viagra or Cialis — including men with performance anxiety-driven ED, men with neurological causes, and men who simply do not respond to PDE5 inhibition.
PT-141 is typically administered as a subcutaneous injection 45 minutes before anticipated sexual activity. Side effects can include nausea (especially at higher doses), flushing, and headache. It is not for daily use and should not be used more than 8 times per month per FDA guidance for the female formulation.
The appeal of PT-141 is its unique mechanism. For men whose ED is driven by low desire, blunted arousal, or psychological factors, a drug that works on the brain's arousal center rather than the plumbing can be more effective than a drug that increases blood flow to a penis the brain is not sufficiently arousing. For more on peptide-based therapies including PT-141, see our complete guide to peptide therapy.
Lifestyle interventions
Lifestyle changes are the most underrated treatment for erectile dysfunction. They lack the pharmaceutical industry's marketing budget, they require sustained effort, and they take weeks to months to show results. But they address root causes, they improve every other aspect of health simultaneously, and their effects are durable.
Exerciseis the single most evidence-supported lifestyle intervention for ED. Aerobic exercise improves endothelial function, increases nitric oxide production, enhances cardiovascular fitness, reduces insulin resistance, promotes weight loss, and boosts testosterone. Zone 2 cardio — sustained moderate-intensity exercise where you can maintain a conversation but it is not comfortable — is particularly effective at improving vascular function. Resistance training increases testosterone, improves body composition, and enhances insulin sensitivity. A meta-analysis of exercise interventions for ED found that aerobic exercise alone improved erectile function by an effect size comparable to PDE5 inhibitors in men with vascular or metabolic ED.
Weight loss directly improves erectile function. Every 10 pounds of excess weight a man loses is associated with measurable improvement in erectile function scores. Weight loss reduces aromatase activity (lowering estrogen), improves insulin sensitivity, reduces systemic inflammation, improves endothelial function, and in many cases raises testosterone levels. For severely obese men, weight loss may be the single most impactful intervention available.
Dietary changessupport vascular health and hormone production. The Mediterranean diet — rich in vegetables, fruits, whole grains, olive oil, fish, and nuts — is associated with lower rates of ED and improved endothelial function. Reducing processed foods, added sugars, and refined carbohydrates improves insulin sensitivity and reduces systemic inflammation.
Sleep optimizationrestores the hormonal environment needed for sexual function. Prioritizing 7–9 hours of sleep, treating sleep apnea if present, and maintaining consistent sleep-wake timing supports testosterone production, cortisol regulation, and overall neuroendocrine health.
Stress reductionlowers cortisol and allows the parasympathetic nervous system to engage — a prerequisite for erection. Meditation, breathing exercises, therapy, boundary-setting at work, and reducing overstimulation are all evidence-supported approaches.
Pelvic floor exercises— yes, Kegels for men — strengthen the ischiocavernosus and bulbocavernosus muscles that compress the base of the penis during erection, trapping blood and increasing rigidity. A randomized controlled trial found that pelvic floor exercises were as effective as PDE5 inhibitors for some men with venous-leak ED. The exercises are simple: identify the muscles by stopping urine mid-stream, then contract and hold for 5–10 seconds, relax, and repeat 10–15 times, three sets per day. Results typically appear within 8–12 weeks of consistent practice.
Emerging treatments
Several newer treatment modalities are generating significant clinical interest, though the evidence base for each is still maturing.
Low-intensity extracorporeal shockwave therapy (Li-ESWT) is the most promising emerging treatment. It uses low-energy acoustic waves applied to the penile tissue to stimulate angiogenesis (the growth of new blood vessels) and improve endothelial function. The theory is compelling: rather than temporarily increasing blood flow (like PDE5 inhibitors) or addressing an upstream cause (like hormone optimization), shockwave therapy may actually repair the vascular damage causing ED. Clinical evidence is growing, with multiple randomized controlled trials showing improvements in erectile function scores, particularly in men with mild to moderate vascular ED. The treatment is typically administered as a series of 6–12 sessions over several weeks. It is noninvasive and has minimal side effects. The main limitations are the lack of long-term follow-up data and the variability in protocols and devices across providers.
PRP therapy (the P-shot)involves injecting platelet-rich plasma derived from the patient's own blood into the penile tissue. The growth factors in PRP are theorized to stimulate tissue regeneration and improve blood flow. The evidence base is limited to small studies and case series, and the treatment is not FDA-approved for ED. Results are highly variable. Some patients report significant improvement; others notice little change. Until larger, well-designed trials are published, PRP for ED should be considered experimental.
Stem cell therapy for ED is in the early stages of clinical research. The concept is to inject stem cells into the corpora cavernosa to regenerate damaged smooth muscle and endothelial tissue. Animal studies have shown promising results, and a handful of small human trials have reported improvements. However, this remains a strictly experimental therapy. Any clinic offering stem cell therapy for ED as a proven treatment is overstating the evidence. Watch this space, but do not pay premium prices for a treatment that has not yet been validated.
ED and your partner
Erectile dysfunction does not happen in a vacuum. It happens in the context of a relationship, and it affects both people in that relationship. This section exists because most ED resources treat it as a solo medical problem to be solved by the man, alone, ideally without his partner even knowing. That framing is both inaccurate and counterproductive.
For the partner, ED can trigger a cascade of insecurity. The most common initial reaction is to internalize it: "He is not attracted to me anymore." "I am not enough." "There must be someone else." These responses are understandable and almost always wrong. Erectile dysfunction is a physiological or psychological condition. It is not a measure of attraction. A man can be deeply attracted to his partner and still be unable to achieve or maintain an erection because his testosterone is low, his blood vessels are compromised, his cortisol is elevated, or his anxiety has hijacked his nervous system. The erection is a downstream output of multiple biological systems, not a voluntary response to desire.
Communication is the most important intervention a couple can make. The man needs to be able to talk about what is happening without shame, and the partner needs to hear it without taking it personally. This is difficult. Sexual performance is deeply tied to identity for many men, and vulnerability about sexual failure goes against decades of cultural conditioning. But avoidance makes everything worse. When a man starts avoiding sexual situations to prevent the embarrassment of failing, the partner interprets the avoidance as rejection, which deepens the insecurity, which adds relationship stress, which worsens the ED. The cycle is predictable and destructive.
Couples who address ED together consistently have better outcomes than men who try to handle it alone. "Handling it alone" often means secretly taking Viagra and hoping the partner does not notice, which creates its own set of anxieties (will it work tonight? what if she finds the pills? what if it stops working?). Bringing the partner into the conversation — sharing the diagnosis, explaining the treatment plan, involving them in lifestyle changes — transforms ED from a source of shame into a shared health challenge. Partners can be enormously supportive when given the information and context they need.
For partners reading this: his ED is not about you. It is not a rejection. It is not a choice. Ask him about it gently. Let him know you are on his team. Encourage him to get a proper medical evaluation, including comprehensive hormone testing, rather than just taking a pill. Your support will make a material difference in his willingness to seek help and his outcomes once he does.
When to see a doctor
Not every episode of erectile difficulty requires a medical evaluation. A single instance of failing to achieve or maintain an erection is almost always situational — too much alcohol, extreme fatigue, high stress, performance anxiety with a new partner. These are normal occurrences and do not indicate a clinical problem.
You should seek medical evaluation when:
- ED persists for 3 months or longer. The clinical threshold for diagnosing erectile dysfunction is a persistent pattern over multiple encounters across at least several weeks. If you have been experiencing difficulty getting or maintaining erections for 3 months, it is time for a workup.
- ED is sudden in onset. If you went from normal erectile function to complete inability overnight, the cause is more likely psychological (acute stress, performance anxiety, relationship crisis) or medication-related (new prescription, dosage change). Sudden onset warrants evaluation but also points toward a more readily treatable cause.
- ED is gradual in onset.A slow, progressive decline in erectile quality over months or years is more suggestive of a physical cause — hormonal decline, vascular disease, metabolic deterioration. This pattern is the one that most urgently requires comprehensive investigation.
- You are over 40 with new-onset ED. Given the established link between ED and cardiovascular disease, any man over 40 developing ED for the first time should receive cardiovascular screening in addition to hormonal and metabolic testing. Your erection problem may be telling you something about your heart that is more important than the erection itself.
- You have other symptoms. If ED is accompanied by fatigue, weight gain, mood changes, brain fog, decreased motivation, or loss of muscle mass, the presentation is strongly suggestive of a hormonal cause. Do not treat these as separate problems. They are likely connected, and a comprehensive evaluation will reveal the common thread.
When you see a physician for ED, insist on a comprehensive evaluation. If your doctor wants to prescribe Viagra without drawing labs, ask for the labs. Specifically request the hormone panel described above (total and free testosterone, estradiol, SHBG, thyroid, fasting insulin, lipid panel, DHEA-S). You are entitled to know why you have ED, not just to receive a medication that works around it.
Frequently asked questions
Is erectile dysfunction permanent?
In most cases, no. The majority of erectile dysfunction is treatable and often reversible, particularly when the underlying cause is identified and addressed. Hormonal causes respond well to optimization. Lifestyle-related ED improves with weight loss, exercise, and behavioral changes. Psychological ED responds to therapy and, when performance anxiety is the driver, often resolves once the cycle is broken. Vascular ED may not be fully reversible if significant arterial damage has occurred, but it can be substantially improved with cardiovascular risk factor management, PDE5 inhibitors, and emerging treatments like shockwave therapy. The cases where ED is truly permanent tend to involve severe nerve damage (such as post-radical prostatectomy with bilateral nerve transection) or advanced vascular disease. For the vast majority of men, ED is a treatable condition, not a life sentence.
Can low testosterone cause erectile dysfunction?
Yes. Low testosterone is one of the most common causes of ED and the most frequently underdiagnosed. Testosterone drives libido (sexual desire) and plays a direct role in the nitric oxide signaling pathway that initiates erections. Men with low testosterone often experience both reduced desire and reduced erectile quality — a pattern that distinguishes hormonal ED from purely vascular ED (where desire is preserved but erections are impaired). The complicating factor is that "low" testosterone is defined differently depending on whether you are using population-derived reference ranges or symptom-based clinical assessment. A man at 320 ng/dL is "normal" by lab standards and functionally hypogonadal by clinical standards. If your testosterone is in the lower third of the reference range and you have symptoms, you have a hormonal contribution to your ED regardless of what the lab report says.
Does Viagra work for everyone?
No. PDE5 inhibitors like sildenafil (Viagra) are effective for approximately 70–80% of men. They work best for vascular ED where the primary issue is inadequate blood flow. They are less effective or ineffective in cases where the underlying cause is neurological (nerve damage), hormonal (low testosterone without adequate nitric oxide substrate), severely psychological (where the brain is not initiating arousal signals for the drug to enhance), or related to severe venous leak (where blood flows into the penis but drains out too quickly). If Viagra does not work for you, it does not mean ED is untreatable. It means you need a different approach: hormone optimization, PT-141, pelvic floor therapy, psychological intervention, or some combination.
Can I take ED medication with TRT?
Yes, and this combination is extremely common in clinical practice. TRT addresses the hormonal foundation — restoring testosterone levels, libido, energy, and the biochemical substrate for healthy erectile function. PDE5 inhibitors provide an additional boost to blood flow that can be helpful while testosterone levels are still optimizing (the first 4–12 weeks of TRT) or in men whose ED has both hormonal and vascular components. Many men who start TRT with concurrent PDE5 inhibitor use find that they can reduce or discontinue the PDE5 inhibitor over time as their testosterone levels stabilize and lifestyle improvements take effect. The combination is safe, effective, and well-supported in the clinical literature.
Does exercise help erectile dysfunction?
Yes, and the evidence is strong. Regular aerobic exercise improves endothelial function, increases nitric oxide bioavailability, enhances cardiovascular fitness, reduces insulin resistance, lowers blood pressure, promotes weight loss, reduces stress, improves sleep quality, and can increase testosterone levels. Multiple meta-analyses show that aerobic exercise produces clinically meaningful improvements in erectile function, with effect sizes comparable to PDE5 inhibitors in men with mild-to-moderate vascular or metabolic ED. Resistance training adds additional benefit through testosterone optimization and body composition improvement. The minimum effective dose appears to be approximately 150 minutes per week of moderate-intensity aerobic exercise, though more produces greater benefit. Exercise is not a replacement for medical treatment in severe ED, but it is a foundational intervention that improves outcomes regardless of the primary cause.
At what age does erectile dysfunction start?
ED can occur at any age, but prevalence increases significantly with each decade. Approximately 8% of men in their 20s report some degree of ED. That figure rises to roughly 11% in the 30s, 40% by age 40, 50–60% by age 60, and approaching 70% by age 70. However, these numbers are misleading if interpreted as evidence that ED is an inevitable consequence of aging. Age-related increases in ED are driven by age-related increases in the conditions that cause ED: declining testosterone, accumulating vascular damage, increasing rates of diabetes and metabolic syndrome, weight gain, medication use, and reduced physical activity. A healthy, hormonally optimized, physically active 60-year-old has dramatically lower ED risk than a sedentary, overweight, hormonally depleted 45-year-old. Age is a risk factor. It is not a cause. And the age-related risk factors are largely modifiable.